glp-1 drugs alcohol Anti-Obesity Rx and and Substance Use Disorders GLP-1 plus therapy can reduce

[26], with permission from Taylor & Francis

The exact dose depends on your weight, comorbidities, kidney function, and disease activity, and should always be determined by your prescribing physician

Furthermore, liraglutide, subcutaneous semaglutide, and tirzepatide are approved for chronic weight management regardless of diabetes status

Adam Evans, MD, a reproductive endocrinology and infertility specialist at University Hospitals, shares more about these possibilities to help people make informed, confident decisions about their fertility plans and how they may intersect with their weight loss goals

To compete effectively, there are a variety of approaches manufacturers may take to ensure patients can easily access their therapies